We Speak Cloud

Our company is formed to forge technology with healthcare. Accelerate the much needed innovation and help deliver precision medicine 10x faster than traditional industry models. Our platform brings drug discovery as precision medicine faster with machine learning (M.L) models uniquely mapped to the DNA structure with the help of on-demand, elastic and resilient Foundational Data Platform.

Drug discovery to delivery of targeted medication and its efficacy is a painstakingly long, risky and complicated process and odds of success finding a general drug for a disease is close to winning a lottery. The high barrier of entry in setting up a discovery lab, right resources, and combination of talented scientists is similar to winning a lottery. At the current pace of drug discoveries and their approval for mass markets; we are decades away from a viable drug and higher barrier of entry upfront cost in millions of dollars.

The past years of technology achievements in computation systems and storage advancements in combination with cloud automation has catapulted the building of the next generation of intelligent software for the healthcare domain. [powered by Machine Learning algorithms and Generative AI models]. The availability of on-demand cloud computing has provided a unique opportunity for the community to find drugs at a faster rate and lower capex. Increased costs and decades long waits on drug design in the traditional lab setup solutions are phasing out in favor of A.I run cloud augmented digital labs.

A.I helping accelerate the drug discovery process by integrating and aggregating the data points across lab experiment projections, in-vivo trial outcomes, human genome data, and protein with enzyme information as a common foundational layer of parsable information.
Experimentation using Machine Learning models using in-silico design of fully synthetic small molecules and high throughput mapping of structure to activity relationships is helping discover molecules with drug-like properties efficiently and at a faster rate and cheaper cost.

We model and interpret ensembles of various targeted M.L. models by overlaying them with the foundational data mine. The platform allows scientists to decode complex experimentation results and help identify effective individual centric therapies that unlock new therapeutic inventions for the patients.